Valeant is committed to marketing and developing effective medicines in the infectious disease category. Valeant currently markets three infectious disease products, Infergen(Interferon alfacon-1), Ancotil/Ancobon(Flucytosine) and Virazole(ribavirin for inhalation); and licenses the rights to ribavirin to Schering-Plough for Rebetolē¢nd F. Hoffman La-Roche for Copegus.
ChemNet is a registered trademark of Zhejiang NetSun Co., Ltd.
Global Chemical Exchange, China Chemical Network and ChemNet.com are services
of Zhejiang NetSun Co., Ltd.